ES2053091T3 - 16alfa,17beta-metilen-estra-4,9-dien-3-onas sustituidas en 11beta. - Google Patents

16alfa,17beta-metilen-estra-4,9-dien-3-onas sustituidas en 11beta.

Info

Publication number
ES2053091T3
ES2053091T3 ES90250202T ES90250202T ES2053091T3 ES 2053091 T3 ES2053091 T3 ES 2053091T3 ES 90250202 T ES90250202 T ES 90250202T ES 90250202 T ES90250202 T ES 90250202T ES 2053091 T3 ES2053091 T3 ES 2053091T3
Authority
ES
Spain
Prior art keywords
group
estra
dien
alkyl
metilen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90250202T
Other languages
English (en)
Inventor
Helmut Dr Kasch
Reimar Dr Krieg
Anatoli Kurischko
Kurt Prof Dr Ponsold
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DD33148189A external-priority patent/DD289536A5/de
Priority claimed from DD33181989A external-priority patent/DD289538A5/de
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2053091T3 publication Critical patent/ES2053091T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C07J53/004—3 membered carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL INVENTO SE REFIERE A UNA NUEVA 11(BETA) 16 (ALFA), 17(ALFA) FORMULA (I), TRATA DE UN PROCEDIMIENTO PARA LA PRODUCCION DEL COMPUESTO DE FORMULA (I); RESEÑA LA ACTIVIDAD ANTIESTAGENA DEL COMPUESTO DE FORMULA (I) Y DESCRIBE LA APLICACION DEL COMPUESTO DE FORMULA (I) PARA LA PRODUCCION DEL MEDICAMENTO. SIENDO: R1 METILO O ETILO; R (AL CUADRADO) HIDROGENO O ALQUIL, ALCOXIMETILO, ALCANOILO, ALCOXICARBONILO CON C1 A 6, O Z-METOXIETILO, Z-HIDROXIETILO, 2 ILO CON UN RESTO ALQUILO DE C1 A 4; R3 VINILO, ALQUILO DE C1 A 6 O UN RESTO FENILO PARA SUSTITUIDO CON -OCH3-, -SCH3-, -N(CH3)2-, -NHCH3, -CN O UN GRUPO ALQUILO DE C1 A 4 Y X OXIGENO, UN GRUPO METOXIAMINO N-OCH3, UN HIDROXIMINO N-OH O UN TIOCETAL CICLICO CON C2 A 3 EN EL ANILLO.
ES90250202T 1989-08-04 1990-08-06 16alfa,17beta-metilen-estra-4,9-dien-3-onas sustituidas en 11beta. Expired - Lifetime ES2053091T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DD33148189A DD289536A5 (de) 1989-08-04 1989-08-04 Verfahren zur herstellung von 17-alkoxy-11beta-aryl-16alpha, 17alpha-methylen-gona-4,9-dienen
DD33181989A DD289538A5 (de) 1989-08-16 1989-08-16 Verfahren zur herstellung von 11 beta-substituierten 16 alpha, 17 alpha-methylen-gona-4,9-dienen

Publications (1)

Publication Number Publication Date
ES2053091T3 true ES2053091T3 (es) 1994-07-16

Family

ID=25748291

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90250202T Expired - Lifetime ES2053091T3 (es) 1989-08-04 1990-08-06 16alfa,17beta-metilen-estra-4,9-dien-3-onas sustituidas en 11beta.

Country Status (8)

Country Link
US (1) US5162312A (es)
EP (1) EP0411736B1 (es)
JP (1) JP3135564B2 (es)
AT (1) ATE105299T1 (es)
DE (1) DE59005594D1 (es)
DK (1) DK0411736T3 (es)
ES (1) ES2053091T3 (es)
WO (1) WO1991001994A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0683172T3 (da) * 1994-05-19 1998-03-30 Akzo Nobel Nv 11,21-bisphenyl-19-norpregnanderivater
US6900193B1 (en) 1996-05-01 2005-05-31 The United States Of America As Represented By The Department Of Health And Human Services Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents
PT900234E (pt) 1996-05-01 2000-12-29 Us Gov Health & Human Serv Derivados de progesterona substituidos em 21 que podem ser utilizados como novos agentes antiprogestativos
IL123195A (en) * 1997-02-21 2002-11-10 Akzo Nobel Nv Steroid compounds with anti-pregnancy activity and against bone thinning, preparation and pharmaceutical preparations containing them
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
DE19917979A1 (de) * 1999-04-21 2000-10-26 Clariant Gmbh Verfahren zur Herstellung von substituierten Phenyl-boronsäuren
US7981927B2 (en) 2007-03-07 2011-07-19 Janssen Pharmaceutica N.V. Steroids derivatives as selective progesterone receptor modulators
ATE536362T1 (de) * 2009-05-22 2011-12-15 Heyl Chem Pharm Verfahren zur synthese von dienogest aus estron-3-methylether

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646074A (en) * 1969-11-26 1972-02-29 Searle & Co 3 17-dioxygenated 16alpha 17alpha-methano-5alpha-androstanes and unsaturated congeners
DE3111951A1 (de) * 1981-03-23 1982-09-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 7(alpha)-alkoxycarbonyl-15ss-methylen-4-androstene, verfahren zu ihrer herstellung und verwendung als arzneimittel

Also Published As

Publication number Publication date
WO1991001994A1 (de) 1991-02-21
ATE105299T1 (de) 1994-05-15
EP0411736A1 (de) 1991-02-06
DE59005594D1 (de) 1994-06-09
US5162312A (en) 1992-11-10
EP0411736B1 (de) 1994-05-04
JP3135564B2 (ja) 2001-02-19
JPH05509287A (ja) 1993-12-22
DK0411736T3 (da) 1994-09-19

Similar Documents

Publication Publication Date Title
ATE110075T1 (de) 1,2-benzisoxazolderivate, verfahren zu deren herstellung, und sie enthaltende pharmazeutische zusammensetzungen.
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
ATE132144T1 (de) Chalkonderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
ES2053091T3 (es) 16alfa,17beta-metilen-estra-4,9-dien-3-onas sustituidas en 11beta.
DE2965904D1 (en) 3,20-dioxo-4,9-diene-21-hydroxy-steroid compounds, process for their preparation, their use in medicines and pharmaceutical compositions containing them
IL80619A0 (en) 3-oxadiazole and 3-carboxylic acid ester beta-carboline derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
ATE53032T1 (de) 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
HUT50164A (en) Process for production of derivatives of 6-phenil /piperazinil-alkyl/-1h, 3h-pirimidin-2,4-dion and medical compositions containing them
ATE105298T1 (de) Antigestagene 11beta-aryl-16alpha, 17alphacyclohexano-estra-4,9-diene.
ATE108440T1 (de) Arylaralkylether, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ATE193531T1 (de) Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten
ATE107298T1 (de) 3-aminochroman-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE59800034D1 (de) 11 Beta-Benzaldoxim-9 Alpha, 10 Alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
ATE59647T1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ATE19879T1 (de) Furyloxazolylessigsaeure-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68906827D1 (de) Phenothiazinderivate, deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE180406T1 (de) Erythromycinderivate
ATE6649T1 (de) 5-cyan-prostacyclinderivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel.
JPS56131551A (en) Tyrosine derivative and medicinal use
ATE29133T1 (de) Troponon-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung.
ES8300675A1 (es) Procedimiento de preparacion de derivados de etanolamina.
DE59204302D1 (de) 14Alpha,16alpha-Ethano- und 14alpha,16alpha-Ethenoestratriene.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 411736

Country of ref document: ES